Drug Shortage Report for HUMATROPE
| Report ID | 168052 |
| Drug Identification Number | 02243078 |
| Brand name | HUMATROPE |
| Common or Proper name | Somatropin for injection |
| Company Name | ELI LILLY CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SOMATROPIN DILUENT |
| Strength(s) | 12MG 3.15ML |
| Dosage form(s) | POWDER FOR SOLUTION LIQUID |
| Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
| Packaging size | Combination package containing 12 mg humatrope sterile lyophilized powder in a 3.5 mL cartridge and 3.15 mL prefilled diluent syringe |
| ATC code | H01AC |
| ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-11-09 |
| Actual start date | 2022-11-01 |
| Estimated end date | 2023-04-28 |
| Actual end date | 2023-03-23 |
| Shortage status | Resolved |
| Updated date | 2023-03-24 |
| Company comments | For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
| Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-08-26 | English | Compare |
| v2 | 2022-08-26 | French | Compare |
| v3 | 2022-09-13 | English | Compare |
| v4 | 2022-09-13 | French | Compare |
| v5 | 2022-11-01 | English | Compare |
| v6 | 2022-11-01 | French | Compare |
| v7 | 2022-11-02 | English | Compare |
| v8 | 2023-03-23 | English | Compare |
| v9 | 2023-03-23 | French | Compare |
| v10 | 2023-03-24 | English | Compare |
Showing 1 to 10 of 10